NoticeMHRA
Competition: point of care diagnostics at the front line
£500k is available to fund the development of novel PoC diagnostics devices.
First published: Jul 22, 2019Last updated: Jul 30, 2019Changes: 2
Latest change: Please note we have changed our preference for those platforms aiming to detect specific nucleic acid analytes; Staphylococcus aureus NCTC 10788 should be used instead of the previously stated Bacillus subtilis subsp. Spizizenii.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.